Teligent PE Ratio 2010-2021 | TLGT

Current and historical p/e ratio for Teligent (TLGT) from 2010 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Teligent PE ratio as of November 20, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Teligent PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2021-10-15 0.17 0.00
2021-06-30 0.53 $-0.19 0.00
2021-03-31 0.62 $-2.61 0.00
2020-12-31 0.75 $-7.64 0.00
2020-09-30 0.72 $-8.64 0.00
2020-06-30 2.42 $-9.86 0.00
2020-03-31 2.80 $-8.10 0.00
2019-12-31 4.26 $-4.70 0.00
2019-09-30 9.50 $-6.40 0.00
2019-06-30 6.30 $-5.80 0.00
2019-03-31 11.60 $-8.90 0.00
2018-12-31 13.70 $-8.20 0.00
2018-09-30 39.50 $-6.60 0.00
2018-06-30 34.60 $-7.10 0.00
2018-03-31 33.60 $-3.40 0.00
2017-12-31 36.30 $-2.30 0.00
2017-09-30 67.10 $-2.30 0.00
2017-06-30 91.50 $-1.60 0.00
2017-03-31 78.10 $-1.90 0.00
2016-12-31 66.10 $-2.30 0.00
2016-09-30 76.00 $-2.40 0.00
2016-06-30 71.40 $-2.40 0.00
2016-03-31 49.00 $-2.20 0.00
2015-12-31 89.00 $-2.00 0.00
2015-09-30 65.40 $0.10 654.00
2015-06-30 63.00 $0.60 105.00
2015-03-31 81.60 $0.80 102.00
2014-12-31 88.00 $0.80 110.00
2014-09-30 93.20 $-0.20 0.00
2014-06-30 53.10 $-0.20 0.00
2014-03-31 56.50 $-0.20 0.00
2013-12-31 30.50 $-0.30 0.00
2013-09-30 18.20 $-0.50 0.00
2013-06-30 14.30 $-0.90 0.00
2013-03-31 17.10 $-0.90 0.00
2012-12-31 10.40 $-1.00 0.00
2012-09-30 12.40 $-0.80 0.00
2012-06-30 10.30 $-0.50 0.00
2012-03-31 10.90 $-0.60 0.00
2011-12-31 11.50 $-0.70 0.00
2011-09-30 11.00 $-0.70 0.00
2011-06-30 11.10 $-1.40 0.00
2011-03-31 15.30 $-1.80 0.00
2010-12-31 16.80 $-2.20 0.00
2010-09-30 15.10 $-2.70 0.00
2010-06-30 10.10 $-2.40 0.00
2010-03-31 7.10 $-4.10 0.00
2009-12-31 7.80 $-4.70 0.00
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Bausch Health Cos (BHC) Canada $3.012B 2.18
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00